坤恒顺维(688283) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥30,540,087.22, representing a year-on-year increase of 23.09% compared to ¥24,810,530.98 in the same period last year[4] - The net profit attributable to shareholders was -¥723,938.86, a decrease of 123.85% from ¥3,035,110.99 in the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥4,057,940.09, down 650.61% from ¥736,988.81 in the same period last year[4] - Basic and diluted earnings per share were both -¥0.01, a decrease of 150.00% from ¥0.02 in the same period last year[4] - Net profit for Q1 2025 was a loss of CNY 723,938.86, compared to a profit of CNY 3,035,110.99 in Q1 2024, indicating a significant decline[19] - The company's basic earnings per share for Q1 2025 was CNY -0.01, down from CNY 0.02 in Q1 2024[19] Cash Flow and Investments - The company reported a net cash flow from operating activities of -¥31,270,892.86, compared to -¥25,883,724.12 in the previous year[4] - Cash flow from operating activities for Q1 2025 was a net outflow of CNY 31,270,892.86, worsening from a net outflow of CNY 25,883,724.12 in Q1 2024[20] - Net cash flow from investing activities was -$2,705,492.77, a significant improvement from -$71,321,838.26 in the previous period[21] - Total cash and cash equivalents at the end of the period decreased to $185,463,590.94 from $220,176,124.51, reflecting a net decrease of $34,118,345.63[21] - Cash outflow from investing activities totaled $62,911,624.28, down from $71,321,838.26 year-over-year[21] - Cash outflow related to financing activities was $141,960.00, slightly lower than $155,446.20 in the previous period[21] Research and Development - Research and development expenses totaled ¥13,094,537.75, an increase of 10.56% from ¥11,844,170.14 year-on-year, accounting for 42.88% of operating revenue[5] - Research and development expenses increased to CNY 13,094,537.75 in Q1 2025, compared to CNY 11,844,170.14 in Q1 2024, representing an increase of 10.6%[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,158,618,533.37, a decrease of 1.62% from ¥1,177,747,047.43 at the end of the previous year[5] - Total liabilities decreased to CNY 188,334,869.67 in Q1 2025 from CNY 207,143,669.70 in Q1 2024, a reduction of 9.0%[18] - The company has a long-term equity investment valued at ¥1,735,048.64, slightly down from ¥1,814,424.15[15] - Total liabilities include accounts payable of ¥55,986,209.18, down from ¥69,871,427.41[15] - Accounts receivable decreased to ¥183,653,389.76 from ¥202,605,727.02[14] - Inventory increased to ¥129,055,991.98 from ¥106,959,309.18, indicating a growth of approximately 20.6%[14] Shareholder Information - Total number of common shareholders at the end of the reporting period is 2,272[11] - The largest shareholder, Zhang Jilin, holds 36,308,429 shares, representing 29.81% of total shares[11] - The company has no significant changes in the shareholder structure or related party transactions during the reporting period[12] Other Income and Expenses - Government subsidies recognized as other income increased year-on-year, contributing positively to the financial results[9] - The company reported a significant increase in other income to CNY 4,029,520.01 in Q1 2025, up from CNY 2,168,471.98 in Q1 2024, a growth of 86.0%[18] - The company’s financial expenses showed improvement, with a net financial cost of CNY -2,536,563.47 in Q1 2025, compared to CNY -3,963,181.82 in Q1 2024[18] Accounting Practices - The company did not apply new accounting standards starting from 2025, indicating stability in financial reporting practices[21]